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Background: The partograph is currently the main tool available to support decision-making of health professionals
during labour. However, the rate of appropriate use of the partograph is disappointingly low. Apart from limitations
that are associated with partograph use, evidence of positive impact on labour-related health outcomes is lacking.
The main goal of this study is to develop a Simplified, Effective, Labour Monitoring-to-Action (SELMA) tool. The primary
objectives are: to identify the essential elements of intrapartum monitoring that trigger the decision to use interventions
aimed at preventing poor labour outcomes; to develop a simplified, monitoring-to-action algorithm for labour
management; and to compare the diagnostic performance of SELMA and partograph algorithms as tools to
identify women who are likely to develop poor labour-related outcomes.
Methods/Design: A prospective cohort study will be conducted in eight health facilities in Nigeria and Uganda
(four facilities from each country). All women admitted for vaginal birth will comprise the study population
(estimated sample size: 7,812 women). Data will be collected on maternal characteristics on admission, labour
events and pregnancy outcomes by trained research assistants at the participating health facilities. Prediction
models will be developed to identify women at risk of intrapartum-related perinatal death or morbidity (primary
outcomes) throughout the course of labour. These predictions models will be used to assemble a decision-
support tool that will be able to suggest the best course of action to avert adverse outcomes during the course
of labour. To develop this set of prediction models, we will use up-to-date techniques of prognostic research,
including identification of important predictors, assigning of relative weights to each predictor, estimation of the
predictive performance of the model through calibration and discrimination, and determination of its potential
for application using internal validation techniques.
Discussion: This research offers an opportunity to revisit the theoretical basis of the partograph. It is envisioned
that the final product would help providers overcome the challenging tasks of promptly interpreting complex
labour information and deriving appropriate clinical actions, and thus increase efficiency of the care process,
enhance providers’ competence and ultimately improve labour outcomes.
Please see related articles ‘http://dx.doi.org/10.1186/s12978-015-0027-6’ and ‘http://dx.doi.org/10.1186/s12978-015-0028-5’.
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Labour complications are an important cause of mortal-
ity, morbidity and long-term disabilities for both mothers
and babies, particularly in under-resourced settings [1]. A
substantial proportion of these severe outcomes occur
in the community or at primary level health facilities,
where women often deliver alone or assisted by semi-
skilled birth attendants. In many health facilities, delays in
implementing appropriate interventions often result in
severe adverse outcomes for mothers and babies. Applying
interventions when they are not medically indicated (e.g.
caesarean sections, labour induction/augmentation) can
also lead to iatrogenic complications, avoidable suffering
and inequitable distribution of limited resources [2,3].
The identification and appropriate management of
women at high risk of labour complications (including at
the first contact with the health system), careful monitoring
throughout labour and childbirth, timely use of effective
interventions (e.g. labour augmentation, assisted vaginal
delivery and caesarean section) together with appropriate
neonatal resuscitation would avert most of the avoidable
intrapartum related maternal and perinatal deaths. The
partograph is the main tool to track the progress of labour
and its use is generally regarded as essential for appropriate
labour monitoring. However, a major obstacle for improv-
ing birth outcomes is that intrapartum monitoring with the
partograph is a time consuming task and it is known that
partograph is either not used or incorrectly used in most
low and middle-income countries [4-7]. Time constraints,
staff shortage, lack of knowledge and negative attitude
among healthcare providers were some of the obstacles
noted to hinder appropriate use of the partograph [8,9]. In
busy labour wards in under-resourced settings, overloaded
health professionals often struggle to provide appropriate
monitoring for all women. Another major limitation is that
making sense of all relevant information to derive appropri-
ate actions is not always straightforward. Therefore, a novel
approach to improving labour monitoring and manage-
ment is urgently needed.Rationale for developing a new tool for labour
monitoring
General curves of normal labour progress were devel-
oped by Friedman using graphico-statistical analyses in
the 1950’s. Friedman reported that cervical dilatation
follows a sigmoid curve for most women and his work is
considered the basis of the “1 cm/hr rule”. This rule is
commonly used in clinical settings as the reference
slowest-yet-normal cervical dilatation rate during active
first phase of labour (from the onset of maximum slope
to complete dilatation) [10]. Building on Friedman’s
original work, Philpott and Castle developed the parto-
graph in the early 1970’s [11-13]. The partograph is agraphic tool displaying length of labour in hours (x -axis)
and cervical dilatation in centimetres (y-axis). Key features
of this tool are the alert and action lines, which are meant
to function as triggers of interventions during labour. The
alert line is straight/linear and represents a cervical dilata-
tion rate of 1 cm/hr. The action line is parallel to the alert
line and it is displayed four hours to the right of the alert
line. Thus, the partograph has an underlying algorithm
aimed at identifying women who are likely to present
labour-related poor outcomes. Also anchored in the
“1 cm/hr rule”, O’Driscoll and colleagues proposed during
the 1970’s the Active Management of Labour (AML) as a
package of interventions aiming at reducing the propor-
tion of women with labour progressing at cervical dilation
rates lower than 1 cm /hr [14,15]. A product of that era,
the partograph, has since been promoted as an essential
tool for assessing labour progress.
However, despite the efforts of major international
organizations to increase the use of the partograph in
labour monitoring, the rate of appropriate use of the
partograph for labour management is disappointingly
low [4-7]. This could partly be because obtaining the
information needed in a timely manner and plotting it
into the partograph can be a complex task, particularly
in busy, understaffed units. Another limitation is that
interpreting the information available and deriving ap-
propriate clinical actions can be a challenging task for
many health providers. Additionally, evidence of positive
impact of the partograph in labour-related health out-
comes is lacking [16] and there is mounting evidence
that the pattern of labour progression among low-risk
women with spontaneous onset of labour differs sub-
stantially from Friedman 1950’s reports [10]. According
to Friedman studies, only 10% of women in labour
would cross the “alert line”, but Philpott and Castle had
observed 21.8% of African women crossing the “alert
line” [10-13]. Similarly, the 1994 WHO partograph study
showed that 30.9% of women in labour crossed the “alert
line” [17]. More recently, Orji and colleagues, studying
Nigerian women in labour, found that 34.8% of nulli-
paras crossed the “alert line” and 18.5% crossed the
action line [18]. Many factors could explain the exist-
ence of different patterns of labour and delivery progress
(e.g. anatomical differences in the pelvic configuration).
Thus, it seems that the straight, linear, 1 cm/hr cervical
dilatation rate may be inappropriate as a universal rule
and unrealistically fast for many women; and its general
application may lead to unnecessary interventions dur-
ing labour [19-21]. Contemporary obstetric attitudes and
practices have changed since Friedman’s work and
currently, there are new statistical and computational
techniques that could allow the development of a tool
that is able to provide customized guidance to health
providers tracking labour progress. Technically, the
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that has the challenging task of discriminating women
that are likely to experience labour complications from
those that are not. Artificial intelligence (AI) techniques
could enable the development of more sophisticated and
potentially more effective classifiers, using dynamic, non-
linear, multidimensional mathematical models. AI applica-
tions currently perform complex tasks and are now
commonplace consumer items, including applications in
medicine, such as automated external defibrillators and
specialized clinical decision support systems (mostly in
oncology, abdominal pain diagnostics, and internal medi-
cine). We have carried out a review of the literature and
did not identify an AI tool for labour management that
could be used in under-resourced settings.
WHO Better Outcomes in Labour Difficulty (BOLD) project
The World Health Organization has initiated a project
to address the quality of facility-based intrapartum care
in under-resourced settings [22]. The goal of this project
is to accelerate the reduction of intrapartum-related ma-
ternal, fetal and newborn mortality and morbidity by ad-
dressing the critical impediments in the process of
labour care and establishing the desired connection be-
tween the health system and the community. This pro-
ject seeks to achieve this goal through the development
of an evidence-based and easy-to-use labour algorithm
and innovative tools that create community demand for
quality intrapartum care.
Simplified, Effective Labour Monitoring-to-Action tool
(SELMA)
In order to address labour monitoring constraints (i.e.
time-consuming and complex monitoring, unclear link
between monitoring and action, making sense of com-
plex information), the concept of a Simplified, Effective,
Labour Monitoring-to-Action (SELMA) tool has been
developed. SELMA will form the basis for the develop-
ment of an optimal labour care algorithm as informed
by a cohort study of women delivering in facilities and
formative research around provider and health system
issues relating to labour management. It is envisioned
that the tool will alleviate the burden of health profes-
sionals during labour, foster optimal labour management
and optimize task shifting by supporting decision-
making of less specialized health professionals. SELMA
would help providers overcome the challenging tasks of
promptly interpreting complex labour information and
deriving appropriate clinical actions, and thus increase
efficiency of the care process, enhance providers’ compe-
tence and ultimately improve labour outcomes. This
protocol describes the quantitative research required for
the development of a simplified, effective monitoring-
to-action algorithm and tool for sub-Saharan Africanwomen in labour. The formative research protocol has
been published separately [23].
Study objectives
Considering that the partograph has underlying algo-
rithms and SELMA will embed algorithms designed to
identify women who are likely to develop labour-related
poor outcomes (and point to actions to prevent them),
the primary objective is to identify the essential elements
(including thresholds and interactions) of intrapartum
monitoring that trigger the decision to use interventions
aimed at preventing poor labour outcomes in order to
develop a simplified, monitoring-to-action algorithm for
labour management. Secondary objectives are to (i)
compare diagnostic performance of SELMA and parto-
graph algorithms as tools to identify women likely to
develop poor labour-related outcomes and; (ii) To
explore the development of modern curves of normal
labour progress for sub-Saharan African women.
SELMA conceptual framework
The main goal of this project is to develop a viable
alternative to the partograph. SELMA will be a tool
designed to:
1. Acquire data (through health providers) about the
characteristics of women in labour, their labour
progression and the setting where labour is taking
place;
2. Keep records and conveniently display intrapartum
monitoring-and-care information;
3. Determine the probability of adverse or favourable
birth outcomes if an intrapartum related
intervention is performed or not performed,
considering the individual characteristics of women
in labour, their labour progression and setting where
labour is taking place;
4. At each point in time, identify the course of action
that prevents the main adverse outcome of interest
and maximizes the likelihood of good outcomes,
based on the individual characteristics of women in
labour, their labour progression and setting where
labour is taking place;
5. Report this information to the health providers.
A diagram representing how SELMA will work is
presented in the Figure 1. In the core of SELMA there
will be a set of interconnected mathematical models
(network) that will be integrated into an evidence-based
clinical algorithm. A key function of this decision unit
will be to assess the clinical situation and prompt health
care providers to either allow labour to progress with
routine monitoring or perform non-medical or medical
interventions, such as intensified clinical assessments,
Figure 1 Diagram of how SELMA will work.
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omy, pharmacologic augmentation, caesarean section/
instrumental vaginal delivery. Figure 2 presents a more
detailed diagram of SELMA decision unit.
In order to build the SELMA decision unit, this pro-
ject aims to answer the following research question: in
women in labour in African health facilities, what are
the elements of intrapartum monitoring (including
thresholds and interactions) that trigger the decision to
use interventions aimed at preventing poor labour out-
comes? In other words, this project aims at determining
the relationship between candidate predictors, intrapar-
tum care interventions and labour outcomes. Candidate
predictors will be obtained from patient demographics,
clinical history, physical examination, characteristics of
labour progress, and previous interventions (e.g. labour
augmentation or amniotomy). The candidate predictors
will be clearly defined and reproducible to maximize
generalizability and applicability of study results to prac-
tice. In addition, the candidate predictors will be measured
using methods applicable to daily practice. We will avoid
overly specialized or high-tech measurement techniques
as this may limit the applicability of the models. Each of
the candidate predictors selected will be available or could




A prospective cohort study is proposed. This study
design was selected because SELMA development will
require the development of a set of integrated prognostic
models related to labour and childbirth. A prospective
cohort study minimizes selection and reporting bias to
the greatest extent possible thereby representing the
strongest design with the greatest likelihood of providinga clear and accurate assessment of the relationship
between candidate predictors (described below) and
composite outcome of interest (i.e. intrapartum related
death and morbidity).
Study sites
This study will be conducted in eight health facilities in
Nigeria and Uganda (four facilities from each country).
Inclusion criteria for health facilities are: a minimum of
1,000 deliveries per year, the major health care facility in
its region, and not a primary health care unit), Intrapar-
tum care provision by skilled birth attendants and
stable access to caesarean section, augmentation of
labour, assisted vaginal delivery and good intrapartum
care practices (e.g. intermittent fetal monitoring, re-
spectful maternity care, good midwifery care).
Study participants
Participants inclusion criteria
All women admitted for vaginal birth with single live fe-
tuses during the first stage of labour (both in latent
phase or early active phase) will comprise the study
population. This includes women undergoing induction
of labour and those with spontaneous labour onset
presenting at cervical dilatation of ≤6 cm. Women will
be considered for inclusion whether or not they primar-
ily receive antenatal care and plan to deliver at the
participating hospital.Participants exclusion criteria
Women with any of the following conditions will be
excluded from the study. Absence of an identifiable fetal
heart sound at hospital admission (presumed intra-uterine
fetal death); advanced first stage of labour (≥7 cm cervical
dilatation); multiple pregnancy; gestational age less than
Figure 2 A preliminary diagram of SELMA decision unit.
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pre-labour C-section; indication for emergency C-Section
or laparotomy on admission; attempted induction of labour,
but no labour achieved, false labour, non-emancipatedminors without a guardian; women who are not capable of
giving consent due to labour distress or any health prob-
lem(s), such as obstetric emergencies (e.g. eclampsia) or
mental disorder.
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Assessment of study eligibility and recruitment of partic-
ipants will be carried out by trained research nurses,
who will approach women for consent for participation
in the study at hospital admission except when they
meet any of the exclusion criteria listed above.Outcomes of interest
The main outcome of interest in this study is intrapar-
tum-related perinatal death and morbidity. This is a
composite outcome comprising intrapartum-related still-
births (i.e. “fresh stillbirths”), very early neonatal deaths
(i.e. neonatal death taking place in the first 24 hours of
birth) and neonates with Apgar score <6 at 5 minutes of
birth (i.e. Apgar score that best indicates neonatal
asphyxia with possible serious adverse consequences).
Table 1 presents prevalence data concerning main out-
comes of interest observed in Nigerian and Ugandan
Hospitals during the three months of data collection of
the WHO Multicountry Survey of Maternal and New-
born Health [24]. The composite outcome is limited to
these three conditions as they represent critical adverse
outcomes with huge global burden where improvement
in the process of intrapartum care could make a differ-
ence. In addition, they can be easily and objectively mea-
sured and thus reduce the potential for detection bias in
the context of a multicenter study setting. More import-
antly, the three adverse newborn outcomes are likely to
share the same set of predictors as they are logically
related in the pathway between pathological insults and
death.
A secondary outcome of interest is a “good perinatal
outcome”. This is a composite outcome that describes
healthy neonates and defined as (i) neonates born alive,
(ii) with Apgar score >7 at 5 minutes, (iii) without death
or severe morbidity at 24 hours of birth or discharge
(whichever comes first).Table 1 Intrapartum-related perinatal death and
morbidity in Nigeria and Uganda
Nigeria Uganda Total
n n N (%)
Hospitals 21 21 42
All Births 12,352 10,923 23,764 (100%)
Intrapartum Fetal Deaths 489 196 685 (2.9%)
Very Early Neonatal Death 70 62 132 (0.6%)
Apgar Score <6 at 5’ 240 147 387 (1.6%)
Intrapartum Related Perinatal
Death & Morbidity*
762 376 1138 (4.8%)
*A total of 66 neonates with Apgar Score < 6 at 5’ died in the first 24 hours
postpartum and are also counted as “Very Early Neonatal Deaths”.Sampling and allocation
Considering that countries had been previously selected
based on the good performance of their local research
teams in the WHO Multicountry Study on Maternal and
Newborn Health and the availability of funds to conduct
research in those countries, a two-stage sampling strat-
egy will be used to sample health facilities and indi-
viduals to participate in this study. In the first stage,
convenience sampling will be used to identify health
facilities fulfilling the inclusion criteria for health facil-
ities. The candidate health facilities will be identified by
the local principal investigators and confirmed by the
WHO coordinating unit after site visits. In the second
stage, trained research staff operating at the participating
health facilities will invite all women admitted for vagi-
nal birth and not presenting with any of the exclusion
criteria above to participate in the study. This cohort
study has only one study group (group allocation strat-
egies are not applicable).
Sample size calculation
In order to achieve the main objective of this project, a
total of 7,812 women in early labour are needed. The sam-
ple size calculation was based on the number of candidate
predictors (N = 20 (maximum number)), the minimum
number of outcomes per predictor considered for model
development and validation (M= 15; 10 in the training set
and 5 in the validation set); I = incidence of the main
outcome of interest (I = 4.8%) and a margin of error
(ME = 25%, also accounting for the clustering effect).
Sample size ¼ N  Mð Þ=Ið Þ  1þMEð Þ
¼ 20  15ð Þ=0:048ð Þ  1 þ 0:25ð Þ
¼ 7; 812
The incidence of the main outcome of interest was
based on data derived from the WHO Multicountry Sur-
vey on Maternal and Newborn Health (WHO MCS) in
Nigeria and Uganda (Table 1).
The number of health facilities was determined based
on the average annual number of births of district/
secondary level hospitals that participated in the WHO
Multicountry Survey on Maternal and Newborn Health
for Nigeria and Uganda and a recent census carried out
among candidate health facilities. Considering a 6-month
data collection period and that only 50% of the women
are in early labour, eligible and willing to participate a
total of eight health facilities (4 per country) will take part
of this study (participating hospitals are expected to
recruit 1,000 women on average).
Drugs and devices
Doptones will be used to assess fetal vital status at
arrival and perform intermittent fetal monitoring during
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receive Doptones and training to use them in order to
standardize fetal heart rate assessment across participat-
ing hospitals.
Innovation in service delivery
All women participating in this study will need to have
the fetal vital status determined at hospital admission
using a Doptone device. Doptones will be used to perform
intermittent fetal monitoring during labour and delivery.
The use of this device may represent an innovation in ser-
vice delivery for some hospitals. The coverage of fetal vital
status monitoring at admission will be one of the study
protocol compliance indicators.
Admission procedure
In each participating health facility, trained research
nurses will screen all women admitted for vaginal birth
using the screening form (Section A of the data collec-
tion form; See Supplementary Additional file 1). Once
the eligibility of the women to participate in this study is
determined, the research nurse will invite the potential
participant to join the study and seek her individual
consent using the individual consent form.
Data collection procedures
Data will be gathered continuously for a period of
6 months at each facility. At each facility, research assis-
tants will be trained to perform data collection and
distributed to ensure coverage of typical hospital shifts.
Through daily visits to the labour ward, delivery room,
postnatal ward, and neonatal intensive care unit, the
research assistants will continuously review the medical
records of all recruited women and obtain information
(if needed) from the attending staff in order to extract
information required to complete the study forms.
Research nurses will ensure that data extraction covers
the three process levels of intrapartum care that are rele-
vant to the study objectives i.e. hospital admission,
labour and childbirth process, and postnatal period/hos-
pital discharge). Data collection will start at hospital
admission and end in the event of maternal death, trans-
fer or hospital discharge. If the woman dies after a live
baby has been born, data collection of infant data will be
carried out until intra-hospital infant’s death, transfer or
hospital discharge. Where a research assistant is a staff
of the participating institution (e.g. a nurse), he/she will
only collect data outside his/her routine working hours
(i.e. data will not be collected by any staff at a time when
such staff is also providing hospital care).
A hospital coordinator will facilitate and oversee the
data collection process and training of local research staff,
conduct training of existing hospital staff on adequatedocumentation of labour events, and transfer completed
data collection forms to the country coordinator.
Follow-up procedures
Data will be collected during hospital stay only. Data
collection will start at hospital admission and will end in
the event of maternal death, transfer or hospital dis-
charge (see further details above). No post-discharge
follow-up will take place.
Criteria for discontinuation of a participant
Women who had initially given consent and later decline
to continue participation will be discontinued from the
study.
Study instruments
This study will use a set of forms that will enable data
collection at individual and facility level. The data man-
agement and analysis team developed draft forms in col-
laboration with the WHO study coordination unit and
the country principal investigators. These draft forms
were reviewed by the study coordinators and study steer-
ing committee. Based on these reviews, relevant changes
and amendments were made to the forms, which were
converted to advanced drafts. The advanced drafts were
pilot-tested in a convenient sample of women in labour
in one hospital of each country. The pilot-test generated
additional changes to the forms. A second round of revi-
sions by the local teams in each country was carried out
during a training workshop. Once the forms were final-
ized, they were produced and dispatched to the partici-
pating hospitals.
For the purpose of this study, four sets of information
will be collected.
1. The static/fixed information that will be collected
at hospital admission, just after recruitment. This
is essentially the information that will not change
during labour (e.g. maternal demographics and
past obstetric characteristics)
2. The dynamic information that is normally
included as part of the partograph (fetal heart
rate, status of the membranes, characteristics of
liquor, cervical dilatation, station of the presenting
part, uterine contractions, oxytocin augmentation
and rate of oxytocin administration, use of
analgesia, IV fluids, temperature, pulse and blood
pressure, and urine assessment). Most of the
information related to labour progress is part of
the partograph and will be collected as recorded
by the labour attendants in the traditional way
that the partograph is completed.
3. The dynamic information that is not part of the
partograph. This information will provide
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effective practices and clinical observations that
are not traditionally captured by the partograph.
This information will be collected as the
partograph information is collected and will
be limited to small amount of data, essentially
related to a) provision of social support,
b) adopted maternal position and mobilization
during labour and childbirth, c) oral food or fluid
intake, and d) maternal wellbeing (e.g. hydration
status).
4. Maternal and infant outcome data.
This information will be recorded on paper forms for
individual study participants, and will include the follow-
ing sections:
 Participant Eligibility: this form will confirm the
eligibility of individual woman to participate in this
study
 Maternal Admission Characteristics: this form
will gather data on the social, demographic,
anthropometric, obstetric and medical characteristics
of study participants at hospital admission. These data
will include maternal age, number of pregnancies
including the index pregnancy (gravidity), previous
births (parity), marital status, educational level
completed, ethnicity, weight, height, use of prenatal
care in index pregnancy, previous caesarean sections,
number of previous abortions (either induced or
spontaneous), presence of any previous uterine surgery,
pre-existing medical problem(s) such as hypertension
and diabetes, onset of labour (induced or spontaneous),
physical findings on general examination (anaemia,
fever, vital signs) and abdominal examination
(frequency and intensity of uterine contractions,
symphysis-fundal height, fetal movements, lie,
presentation and position, fetal heart rate, and
vaginal examination (cervical effacement [degree
of shortening], cervical consistency, cervical
dilatation, status of amniotic membranes, and
characteristics of liquor if membranes are
ruptured, descent of the presenting part relative
to the level of ischial spines.
 First Stage of Labour Events: This form will
collect data on the multiple assessments and
interventions performed during the first stage of
labour. These will include standard labour progress
assessments (uterine contractions, fetal heart rate,
characteristics of liquor, cervical dilatation, descent
of the presenting part, amniorrhexis, presence or
absence of caput succedaneum or molding),
maternal clinical and laboratory observations (pulse,
temperature, blood pressure, urine assessment), andspecific interventions performed during the course
of labour with aim of improving labour experience
and outcomes (use and timing of analgesia,
intravenous fluid administration, oral fluid intake,
ambulation, companionship, oxytocin augmentation
and rate of infusion, assisted vaginal delivery, and
caesarean section).
 Second Stage of Labour Events: This form will
collect data on the multiple assessments and
interventions performed during second stage of labour.
 Indication and Timing of Selected Interventions:
This form will collect additional data concerning the
use of selected intrapartum care interventions,
including indications, reasons for delays, decision-
intervention time (e.g. decision-incision time for
caesarean section) and adverse effects/outcomes
related to these interventions.
 Labour Outcome Data: This form will collect
maternal and neonatal outcomes and data related to
the immediate postpartum period until hospital
discharge. Specifically, data will be collected on
maternal and perinatal intrapartum related death
and morbidity. This will include labour obstruction,
uterine rupture, dystocia-related severe maternal
morbidity or death, intrapartum-related fetal death,
intrapartum-related very early neonatal death
(<24 hours of birth), Apgar score < 6 at 5’ min,
neonatal encephalopathy, and neonatal admission
to intensive care unit.
Project management
The project management will include coordination and
execution of the following activities which require admin-
istrative and clinical research input. The BOLD Project
Steering Group will oversee the progress of the study,
provide technical guidance and make policy decisions
related to the conduct and implementation of the
study. The Project Steering Group is made up of pro-
ject staff at WHO, and lead investigators from Univer-
sity of São Paulo, Brazil; Makarere University, Uganda;
University of Ibadan, Nigeria; and M4ID, Finland. The
project will also receive technical advice regarding its
implementation from a Technical Advisory Group
(TAG) - a multistakeholder group comprising of experts
in epidemiology, clinical obstetrics, midwifery, health
system, service design, information technology, and
programme implementation from both high and low-
income countries.
Preparation for the study
 Site visits before study starts: standardization of
study procedures; procurement of study materials;
verification of recruitment rate.
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collaborators.
 Establishment of communication procedures
between the centres.
 Designation of Data Management and Analysis
Committee
 Finalization of the protocol together with the local
research teams
 Submission of proposal to relevant ethics committees.
 Organization of interim and final collaborators
meetings.
 Preparation of data collection forms and consent
forms.
 Preparation of Manual of Operations.
 Purchase and delivery of Doptones and other
supplies to participating hospitals
 Conducting training workshops and eligibility drills
with simulated and real cases
Data processing and system preparation
On-line data entry and management will be coordinated by
the Data Management and Analysis unit at the University
of São Paulo, Brazil. Data analysis and interpretation will be
done jointly between the Data Management and Analysis
team at the University of São Paulo, and the Project Steer-
ing Group.
Conduct of the study
Coordination activities
 Site visits to monitor study progress.
 Communication with local investigators to monitor
trial progress.
 Communication with the data monitoring
committee of the trial.
Data management and statistical analysis
 Data entry
 Data validation and production of queries
 Correspondence between coordinating centres and
the centres related to queries.
 Monitoring reports: recruitment, loss to follow-up,
completeness of data for main outcomes.
 Statistical and computational analysis: interim
analyses, final analysis.
Data quality assurance
Data collection forms, a manual of operations and a
study database will be developed. Study data will be
collected and managed using REDCap electronic data
capture tools hosted at the Ribeirão Preto Medical
School, University of São Paulo, Brazil. REDCap (Re-
search Electronic Data Capture) is a secure, web-basedapplication designed to support data capture for research
studies, providing: 1) an intuitive interface for validated
data entry; 2) audit trails for tracking data manipulation
and export procedures; 3) automated export procedures
for seamless data downloads to common statistical pack-
ages; and 4) procedures for importing data from external
sources (http://project-redcap.org/). Data will be collected
using paper data collection forms and then entered into
REDCap. Aiming at complete and accurate data, a visual
inspection of the form will be carried out before data
entry; automated rules for detecting data inconsistencies
or discrepancies will also be integrated. Data collection
will be carried out by trained data collectors and will start
at recruitment, e.g. time of admission and finish at the
hospital discharge. Data on candidate predictors collected
prior to the outcomes of interest will be used for analyses.
The majority of the facilities has participated in the Global
Survey/Multicountry Survey Project and has experience
in facility-based studies. Online data entry system will
minimize the data entry errors and facilitate monitoring
and quick resolution of queries and missing data. A man-
ual of operations will be developed to minimize the need
for judgement and interpretation by the data collectors.
The manual of operations will include a description of the
study in general terms, emphasize the importance of
complete and accurate data, and foster the standardization
of data collection. The data collection tools will be
reviewed by other researchers and pre-tested on a con-
venient sample of records and clinical settings. Reviewers
will note their individual experience with both the defin-
itional criteria and the time taken to collect and record
data. Based on the final pre-test, revisions will be made to
both data collection instruments. There will be training
workshops at country-level. Routine hospital data about
the total number of women admitted to the facility and
delivering at the facility will be monitored and compared
to the study data. Validity cross-checks will be performed.
In addition, random cross-checks of 1% of the forms will
be made to ensure that entered data correspond to the
woman in question. The responsible hospital staff member
will maintain a problem log book to document unantici-
pated problems. Technical questions encountered in the
field will be resolved through consultation with the coun-
try coordinators under the supervision of the WHO
coordinating unit.
Data management
Trained research nurses at the participating health
facilities will use paper-based data collection tools to
collect data prospectively. The study coordinator in
each health facility will perform a visual inspection of
each form before data entry. All entries will be de-
identified at the stage of data collection and partici-
pants will be identifiable only by unique identification
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pital coordinator. The hospital coordinator will keep a
copy of the data collection forms of each patient in a
locked cabinet at the health facility until the database
is considered clean and ready for final analysis. The
original data collection forms of each patient will be
sent to the country-level data entry center in weekly
batches. All forms received at the country data entry
centre will also be kept in locked cabinets accessible
only to the data managers and country principal in-
vestigator until the database is ready for final analysis.
Online data entry will be performed in one data-entry
center from each country. These procedures have been
used in previous multicentre trials and proven to be effi-
cient and compliant with the HRP/WHO Standard Operat-
ing Procedures. Similarly, HRP has good experience with
management of online data entry systems from several
international multicentre studies conducted in the past
5 years [24-26]. The online data entry system also mini-
mizes the delays in data queries and completion of incom-
plete forms.
RedCap, an open-source data entry system, will be
used in the study. This system is being used by several
institutions that conduct multicentre trials around the
world. A customized data entry and monitoring system
will be developed in the RedCap platform for this study.
This data entry system will be password-protected and
accessible only to the database managers and study
team. The system will be developed and coordinated by
the study Data Management Unit at the University of
São Paulo, Brazil.Data analysis plan
A detailed plan for statistical and computational analysis
will be developed by the Data Management and Analysis
team in collaboration with the study coordination unit
at WHO before data collection starts. This plan of ana-
lysis will be externally reviewed by an expert panel of
the Bill & Melinda Gates Foundation. Modelling plan
will be developed and implemented at the University of
São Paulo, by a team of experts that includes biostatisti-
cians, computational statisticians, information technol-
ogy specialists and obstetricians.
A summary analysis plan is presented below by pri-
mary objective.Primary Objective # 1 (To identify the essential elements
(including thresholds and interactions) of intrapartum
monitoring that trigger the decision to use interventions
aimed at preventing poor labour outcomes)
For many women, intrapartum care is composed of
expectant monitoring and a supportive, hands-off ap-
proach. Other women may require interventions to avoidcomplications or expedite labour and delivery. During this
process, health professionals are frequently acquiring
information, processing it, and making the decision to
keep monitoring as it is, intensifying the monitoring or
intervening. We intend to mimic this process using artifi-
cial intelligence techniques and split the analysis in four
phases.Phase 1 – Descriptive analysis
Frequencies and proportions will be used to describe the
characteristics of the study population, intrapartum care,
hospital characteristics and labour outcomes.Phase 2 – Determining the baseline risk
Crude and adjusted odds ratios will be used to determine
the relationship between candidate predictors at hospital
admission, intrapartum interventions and labour out-
comes. Candidate predictors include the characteristics of
women, their current and past obstetric and complications
profile, the conditions of the women and the hospital
capacity. Statistical and computational modeling will be
used to determine the baseline risk of poor labour-related
outcomes and the baseline probability of receiving se-
lected intrapartum interventions (i.e. amniotomy, aug-
mentation of labour, caesarean section, operative vaginal
delivery). The analyses will account for clustering effect at
two levels: country and hospital level.Phase 3 – Determining the risk throughout labour and
delivery
Each woman will have multiple data points portraying
her progress during labour and delivery. At each of these
data-points, the relationship between candidate predic-
tors, intrapartum interventions and labour outcomes will
be determined/updated. Statistical and computational
modeling will be used to determine the baseline risk of
poor labour-related outcomes and the baseline probabil-
ity of receiving selected intrapartum interventions (i.e.
amniotomy, augmentation of labour, caesarean section,
operative vaginal delivery). These analyses will account
for clustering effect at three levels: country, hospital and
woman level.
In order to create trends for each variable of interest, a
minimum of three measurements will be collected up to a
maximum of one measurement per hour. In case of more
than one measurement per hour, the assessment with the
largest deviation from normality will be used. This ap-
proach was previously used to develop clinical prognostic
models (e.g. Simplified Acute Physiology (SAP) and Acute
Physiology and Chronic Health Evaluation (APACHE)
scoring systems [27,28].
Probability of good 
outcomes if the intervention 
“X” is NOT performed
Probability of poor 
outcomes if the intervention 
“X” is NOT performed
Probability of good 
outcomes if the intervention 
“X” IS performed
Probability of poor 
outcomes if the intervention 
“X” IS performed
Figure 3 Probability panel for intrapartum decision-making (the
“intervention” “X” could be: continued routine monitoring, amniotomy,
augmentation of labour, caesarean section, or operative vaginal
delivery).
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monitoring (i.e. predictors of intrapartum interventions
and labour outcomes)
Based on the findings of phases 1–3, in phase 4, the pre-
dictors of intrapartum interventions and labour out-
comes (i.e. candidate predictors retained in the models)
will be determined. These predictors will constitute the
essential elements of intrapartum monitoring and action
and will be included in the SELMA tool.
Statistical and computational analysis
Intrapartum care involves critical decision points re-
lated to the use or non-use of various intrapartum
interventions (e.g. augmentation, rupture of membranes,
caesarean section etc.). In order to model this process, it is
first necessary to identify women that are at a high risk of
presenting poor intrapartum related outcomes. We will
use prediction models to identify women at risk of the
composite adverse outcome (and need an intervention)
and use prediction models to suggest the best course of
action to avert this outcome. To develop this set of predic-
tion models we will use the best available techniques in
prognostic research; including identification of important
predictors, assigning relative weights to each predictor,
estimation of the predictive performance of the model
through calibration and discrimination, and determin-
ation of its potential for application using internal val-
idation techniques. Only candidate predictor variables
available for 80% or more of the recruited women will
be included in the analyses.
In terms of modelling, we will explore four analyses
techniques:
 Multilevel logistic regression. This is a standard
statistical technique used in traditional prognostic
research. We will use backward elimination of
candidate predictors with a nominal significance
level of 5%.
 Multilayer perceptron. This is an artificial neural
network technique. We will use back propagation as
supervised learning technique.
 Structural equation modelling. This is a statistical
technique for testing and estimating causal relations
using a combination of statistical data and
qualitative causal assumptions.
 Support vector machines. This is a supervised
learning model that analyzes data to identify
patterns for classification and regression analysis.
The performance of the models derived using these
techniques will be assessed for calibration and discrimin-
atory power. Specific tests will be carried out to assess
performance including calibration plots, the Hosmer-
Lemeshow test, Receiver Operator Characteristics (ROC)curves/C-statistics and R square tests. For each critical
node, the best performing models will be selected.
Primary Objective # 2 (To develop a simplified,
monitoring-to-action algorithm for labour management)
Clinical guidelines and algorithms depicting “global best
practices” for intrapartum care exist [29,30]. The BOLD
project also includes formative research (qualitative
research) aimed at adapting the global best practices to
the reality of intrapartum care in Nigeria and Uganda.
The process of adaptation will consider the expectations,
preferences and needs of women, families and commu-
nities as well as the facility-based health care providers
and the capacity of local health systems. This piece of
work has been submitted as a separate protocol to the
WHO HRP Review Panel on Research Projects [23].
Global best practices together with their local adapta-
tions will form the backbone of a stepwise clinical algo-
rithm used by SELMA. The decision points of this clinical
algorithm will be fed by a network of interconnected
models developed as part of the primary objective #1.
Software will be developed to integrate the stepwise clin-
ical algorithm with the interconnected mathematical
models and allow input and output of information. At
each decision point, and for each intervention evaluated,
the probability panel showed in the Figure 3 will be calcu-
lated. Based on this probability panel, a course of action
that maximizes the risk of good outcomes and minimizes
the risk of poor outcomes will be suggested.
The target users for SELMA are skilled birth attendants,
particularly midwives and non-specialized clinicians (i.e.
clinicians without specialist training in obstetrics but who
also provide care for women in labour).
Secondary Objective # 1 (To compare the diagnostic
performance of SELMA and partograph algorithms as tools
to identify women likely to develop poor labour-related
outcomes)
In the partograph, when the alert line is crossed, the
woman is classified at the category of high risk of
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crosses the action line, she is moved to a category of
very high risk of poor outcomes. Throughout labour and
childbirth SELMA models will be classifying women in
risk categories. These classifiers function as diagnostic
tests and can be assessed as such having the final out-
come as gold standard. Sensitivity, specificity, positive
and negative likelihood ratios and diagnostic odds ratios
will be used to compare the diagnostic performance of
SELMA and the partograph.
Ethical considerations
This is an observational study that will not expose the
study participants to any additional risk. All potential
participants will be approached by trained research
nurses for participation at hospital admission during the
early stages of labour. Women in advanced labour or
who are distressed for any reason at hospital admission
will not be eligible to participate as this may comprom-
ise their ability to freely and clearly decide whether they
are willing to participate or not in this study. The research
assistant will determine if the women are able to provide
consent and will be trained to ensure voluntariness of
consent. Women approached for participation will be
reassured that their decision to participate will not affect
the treatment they receive in the hospital. The research
nurses will be trained to determine when a woman is able
to provide confidential information (e.g. abortion history)
that may not be available in her antenatal records. Such
information will be obtained privately when there is no
risk to compromising labour care (e.g. on the postnatal
ward). All potential participants will receive information
about the study in their language of choice, conforming to
ethical requirements for research involving human sub-
jects. The language will be easy to understand and free of
technical jargons. Participants will be given sufficient time
to reflect on the information and ask questions. Those
who consent to participate in the study will be requested
to sign the informed consent form, and it will be made
clear that they are free to withdraw from the study at any
stage without risk of any negative consequences. For
illiterate women, an impartial witness will be present dur-
ing the entire informed consent reading and discussion.
Both the witness and the individual discussing the consent
will sign and date the consent form. The contact details of
the local investigators, including telephone numbers, will
be made available to the participants should they require
further information and assistance.
Participants will not experience any direct and/or im-
mediate benefits for participating in the study. However,
the study will be gathering information to inform the
development of tools that have the potential to improve
the quality of labour management in the future. Study
participants and other women using or intending to usefacilities for childbirth could indirectly benefit from the
increased scientific knowledge on this topic, which will
ultimately promote women-centred care of high quality
in the facilities in the future. We do not anticipate any
risk to individual participating woman as the participant
information will remain confidential at all times and the
researcher will not know the identities of the partici-
pants through the information gathered. Participants will
not experience any health problems that are a direct
result of participating in the study. However, should any
condition be identified, the women will receive appropriate
care within the health services. There will be no reimburse-
ment or compensation provided to study participants for
taking part in the study. No form of deception will be used
in this study.
The WHO HRP Review Panel on Research Projects
(RP2) comprising of external reviewers and WHO scien-
tific staff reviewed and approved the scientific and tech-
nical content of the study (protocol ID, A65879). Ethics
approval was obtained from the WHO Research Ethics
Review Committee (ERC) and ethics review authorities
responsible for all participating hospitals (Federal Capital
Territory Health Research Ethics Committee and Ondo
State Ministry of Health Research Ethics Review Com-
mittee in Nigeria, and Makerere School of Health
Sciences Research and Ethics Committee in Uganda.
Study timeline
This is a two-year project. It is anticipated that the prep-
arations for this study will take approximately 9 months,
recruitment into the study in the facilities can be com-
pleted in approximately 6 months and analysis can be
completed in another 6 months, leaving three months




For over four decades, the partograph has been pro-
posed as an integral part of labour management with the
aim of helping to discriminate between women with
normal and abnormal labour progression in all settings.
However, in spite of its popularity, it is underused and
the desired improvements in labour outcomes in low-
resource settings remain to be seen due to several fac-
tors. This research was specifically designed to develop a
tool that could overcome the challenges of making sense
of labour information and customizing interventions to
prevent adverse labour outcomes. It challenges and
offers opportunity to revisit the theoretical basis of the
partograph using up to date methodologies that have
been successfully applied in other medical fields.
Based on the proposed research, we expect to develop
a viable alternative to the partograph. As part of this
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intrapartum monitoring, compare diagnostic perform-
ance of SELMA and partograph algorithms as tools to
identify women likely to develop poor labour-related
outcomes and explore the development of modern curves
of normal labour progress for sub-Saharan African women.
Main problems anticipated and proposed solutions
Detailed intrapartum care data is missing
If data on candidate predictors and outcomes are
unavailable or insufficient, valid prognostic modeling
will be impossible. In order to avoid this, the amount of
data that will be collected repeatedly during labour will
be limited to those traditionally recorded on the parto-
graph. Dedicated research nurses will collect data pro-
spectively and concurrently as it is documented by the
health care providers in the case records or on the par-
tograph; if needed, the research nurse will ask health
providers for additional information.
Quality of intrapartum care is poor
If quality of intrapartum care is poor, the ability to gen-
erate meaningful models will be compromised. In order
to avoid this, careful selection of hospitals will be per-
formed. But precautions will be taken to select facilities
that ensure external validity and allow generalizability of
the results.
Data is insufficient to model the relationship of candidate
predictors, interventions and outcomes
If data is insufficient to generate robust models, we will
seek and use other data sources, such as data from the
WHO Multicounty Study on Maternal and Newborn
Health and from other studies that are testing the C-
Models can be used to develop draft models.
Applicability of the results
In order to maximize the applicability of its findings, this
study will be conducted in two African countries, where
the burden of poor outcomes related to labour and
childbirth is high. Health facilities with district-level sta-
tus will be selected also to maximize the applicability of
the results. This project will have a second phase, where
the new tools developed by the BOLD project will be
adapted and tested in a large number of countries, which
also favours the future applicability of results.
Links with other projects
The development of the SELMA algorithm and tool is
part of the BOLD project, a larger initiative with the
overall goal of reducing adverse maternal and infant out-
comes resulting from labour complications through
research, design and implementation of innovative tools.
The BOLD project also includes the development of aPassport for Safer Birth (PSB, another tool being devel-
oped as part of the BOLD project). The BOLD project
has a qualitative, formative research component that will
feed into the final development of SELMA at the imple-
mentation phase. In the future, the findings from this
project may contribute to WHO guidelines on intrapar-
tum care.
Plans for dissemination and use of project results
The results arising from the study will be published in a
reputable peer-reviewed journal. All publications will fol-
low relevant external guidance such as the ‘Uniform
Requirements for Submission of Manuscript to Biomed-
ical Journals’ issued by the International Committee of
Medical Journal Editors (ICMJE). Dissemination of
results to participating institutions and communities
will take place through meetings of stakeholders within
the facilities and the communities. The results of the
study will first be reported to collaborating investiga-
tors. Collaborating investigators will then disseminate
local and collective results to their department and rele-
vant authorities within the countries. There is a public
website (http://www.who.int/pmnch/topics/maternal/
20100914_gswch_en.pdf?ua=1) through which activities
and progress of the project will be documented and
shared. Additionally, a bi-monthly newsletter will be
published and disseminated to all stakeholders through-
out the life span of the BOLD project.
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